Reversible Metronidazole-Induced Encephalopathy With Typical MRI Features Following a Low Cumulative Dose: Case Report
Clinical Medicine Insights: Case Reports · 2026-06 · 19
DOI: 10.1177/11795476261463624 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Medicine Insights: Case Reports, online erschienen am 22.06.2026. Verfasst von Mohammad Adi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Damascus University, Damascus, Syria. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Metronidazole-induced encephalopathy (MIE) is an under-recognised but potentially reversible neurotoxic complication of metronidazole therapy, typically associated with high cumulative doses or underlying comorbidities such as hepatic dysfunction. Classic MRI findings include symmetric T2/FLAIR hyperintensities in the cerebellar dentate nuclei, brainstem, and splenium of the corpus callosum. Case Presentation We report a 64-year-old woman with well-controlled hypertension and type 2 diabetes who developed acute dysarthria, gait instability, and a generalized seizure after a 7-day course of metronidazole totaling 10.5 g. Laboratory evaluation was unremarkable.Stool cultures and pathogen-specific PCR were negative. The MRI shows bilateral symmetric T2/FLAIR hyperintensities in the dentate nuclei, brainstem, and splenium, consistent with MIE. No alternative etiology was identified. This case occurred in an adult without hepatic dysfunction. Metronidazole was discontinued immediately, leading to rapid clinical improvement and complete neurological recovery.
Conclusion
This case highlights that MIE can occur even after short treatment durations and low cumulative doses, particularly in patients without traditional risk factors. Early recognition of the clinical and radiologic features is essential, as prompt drug cessation leads to full reversibility in most cases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Damascus University, Damascus, Syria.
- Faculty of Medicine, Homs University, Homs, Syria.
- Department of Medicine, Termez University of Economics and Service, Termez, Uzbekistan.
- Head of the Department of Medicine, Alfraganus University, Tashkent, Uzbekistan.
- Faculty of Medicine, Tanta University, Tanta, Egypt.
ORCID-Profile: Mohammad Adi
Zitieren
APA
Adi, M., Mostafa, S., Latipov, J., Kuziev, O., & Ashraf, A. (2026). Reversible Metronidazole-Induced Encephalopathy With Typical MRI Features Following a Low Cumulative Dose: Case Report. Clinical Medicine Insights: Case Reports, 19. https://doi.org/10.1177/11795476261463624
Vancouver
Adi M, Mostafa S, Latipov J, Kuziev O, Ashraf A. Reversible Metronidazole-Induced Encephalopathy With Typical MRI Features Following a Low Cumulative Dose: Case Report. Clinical Medicine Insights: Case Reports. 2026;19. doi:10.1177/11795476261463624
BibTeX
@article{Adi2026,
author = {Adi, Mohammad and Mostafa, Shaza and Latipov, Javdat and Kuziev, Otabek and Ashraf, Ahmed},
title = {Reversible Metronidazole-Induced Encephalopathy With Typical MRI Features Following a Low Cumulative Dose: Case Report},
journal = {Clinical Medicine Insights: Case Reports},
year = {2026},
volume = {19},
doi = {10.1177/11795476261463624}
}
EUVIMED